Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | The efficacy and safety of intravenous thrombolysis for stroke treatment in Asian populations

Thang Huy Nguyen, MD, PhD, People’s 115 Hospital, Ho Chi Minh City, Vietnam, discusses the use of intravenous thrombolysis for stroke treatment in Asian populations. Prof. Nguyen emphasizes that data shows intravenous thrombolysis is safe in this population, but there is a need to improve the speed of treatment, potentially using mobile stroke units. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

You know, in Asia, and before we do thrombolysis in my clinical practice, I am afraid of bleeding because it’s based on the data in Asian people. The risk of bleeding with antithrombotics is higher than other people. But when we do some clinical trial in my country, we found that in Asia, the TPA thrombolysis is safe, at least equally effective and safe with other people in the world. But I think it’s for Asians, I think one more thing can improve the benefit of thrombolysis is how we can do it quickly...

You know, in Asia, and before we do thrombolysis in my clinical practice, I am afraid of bleeding because it’s based on the data in Asian people. The risk of bleeding with antithrombotics is higher than other people. But when we do some clinical trial in my country, we found that in Asia, the TPA thrombolysis is safe, at least equally effective and safe with other people in the world. But I think it’s for Asians, I think one more thing can improve the benefit of thrombolysis is how we can do it quickly. Because it’s now in developing countries, very rarely we can start intravenous thrombolysis in the first one hour after the onset. So I wish I can do it quickly. Maybe we need a mobile stroke unit. It can help us to do thrombolysis very quickly. And one more thing is we hope we can have the new neuroprotection because neuroprotection is very easy to use and we don’t need to train doctors to use neuroprotection. So we can use neuroprotection everywhere if they got the benefit before we can go further with IV thrombolysis. Maybe it may be more effective and safer for intravenous thrombolysis.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.